This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Biotech

Chevron Earnings, GDP: What to Watch on Wall Street for Jan. 30

On Friday, January 30th Wall Street wraps up a big earnings week.

01/29/15 - 08:00 PM EST

Dr. Reddy's (RDY) Stock Gained Today on Earnings Beat

  • Tickers in this article:
  • RDY

Dr. Reddy's (RDY) shares were up today after the company reported third quarter results that beat analysts' guidance.

01/29/15 - 04:54 PM EST

Vertex Pharmaceutical (VRTX) Stock Declines Today Following Earnings Realease

Vertex Pharmaceutical (VRTX) Stock Declines Today Following Earnings Realease

  • Tickers in this article:
  • VRTX

Vertex Pharmaceutical (VRTX) shares are falling today after the company reported a wider year over year quarterly loss and analysts' tepid response to the tone of its conference call

01/29/15 - 11:44 AM EST

Dr. Reddy's (RDY) Stock Gained Today on Earnings Beat

Dr. Reddy's (RDY) Stock Gained Today on Earnings Beat

  • Tickers in this article:
  • RDY

Dr. Reddy's (RDY) shares were up today after the company reported third quarter results that beat analysts' guidance.

01/29/15 - 04:54 PM EST

Can Regulus Therapeutics Double Again on Next Hep-C Drug Trial Update?

Can Regulus Therapeutics Double Again on Next Hep-C Drug Trial Update?

New trial data from a group of hepatitis C patients treated with a higher dose of RG-101 are expected in early February, according to Regulus

01/28/15 - 02:28 PM EST

The Absurdity of Flex Pharma IPO: 2 Spices and a Veg Net $86M

The Absurdity of Flex Pharma IPO: 2 Spices and a Veg Net $86M

If the biotech bull market hasn't reached 11 on the absurdity meter quite yet, the Flex Pharma FLKS IPO gets us close.

01/29/15 - 07:44 AM EST

Amgen (AMGN) Stock Declines Today Despite Earnings Beat

Amgen (AMGN) Stock Declines Today Despite Earnings Beat

  • Tickers in this article:
  • AMGN

Amgen (AMGN) shares are falling following the release of the company's fourth quarter earnings results today.

01/28/15 - 12:30 PM EST

Abbot Laboratories (ABT) Stock Gains Today on $5.3 Billion Generic Business Sale Approval

Abbot Laboratories (ABT) Stock Gains Today on $5.3 Billion Generic Business Sale Approval

  • Tickers in this article:
  • ABT

Abbot Laboratories (ABT) shares are rising after the European Commission announced its approval of the company's generic business sale to Mylan (MYL).

01/28/15 - 01:55 PM EST

Novartis (NVS) Stock Gains Today on Earnings Beat

Novartis (NVS) Stock Gains Today on Earnings Beat

  • Tickers in this article:
  • NVS

Novartis (NVS) shares are climbing on the company's strong fourth quarter financial performance.

01/27/15 - 04:15 PM EST

Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill

Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill

Medtronic's $49.9 billion acquisition of Covidien -- the largest tax inversion deal ever -- will leave shareholders with a big tax bill, while Medtronic may pay little or no taxes.

01/28/15 - 06:01 AM EST

Bristol-Myers Squibb (BMY) Stock Falls Today on Weak Guidance

Bristol-Myers Squibb (BMY) Stock Falls Today on Weak Guidance

  • Tickers in this article:
  • BMY

Bristol-Myers Squibb (BMY) shares are declining after it issued weak 2015 guidance today.

01/27/15 - 12:42 PM EST

Pfizer Warns on Outlook but Analysts Optimistic: What Wall Street's Saying

Pfizer Warns on Outlook but Analysts Optimistic: What Wall Street's Saying

  • Tickers in this article:
  • PFE

Pfizer was one of several blue chip companies to warn investors that foreign exchange swings would cut into sales and profit in 2015. Here's what analysts said.

01/27/15 - 12:19 PM EST

Biotech Stock Mailbag: Arena Pharma, Agenus, EnteroMedics

Biotech Stock Mailbag: Arena Pharma, Agenus, EnteroMedics

Biotech columnist Adam Feuerstein answers readers' questions about health care.

01/23/15 - 06:00 AM EST

Egalet (EGLT) Stock Gains Today on Price Target Increase

Egalet (EGLT) Stock Gains Today on Price Target Increase

  • Tickers in this article:
  • EGLT

Egalet (EGLT) shares are climbing after analysts at Canaccord Genuity raised its price target to $18 from $12 today.

01/26/15 - 09:53 AM EST

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

DOW 17,416.85 +225.48 1.31%
S&P 500 2,021.25 +19.09 0.95%
NASDAQ 4,683.4070 +45.4130 0.98%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs